血栓通注射液联合巴曲酶治疗突发性耳聋合并代谢综合征的临床观察
作者:
基金项目:

淮南市科技计划项目(2013A4305)。


Effect of Xueshuantong injection combined with batroxase in the treatment of sudden deafness complicated with metabolic syndrome
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • | |
    摘要:

    目的 探讨血栓通注射液联合巴曲酶治疗突发性耳聋合并代谢综合征的临床效果及对患者血清血液流变学的影响。方法 选择2017年10月—2019年10月淮南东方医院集团总院收治的突发性耳聋合并代谢综合征患者100例,随机分为两组,对照组患者(n=50)给予巴曲酶、补充维生素和营养神经的常规治疗方式;观察组患者(n=50)在对照组治疗基础上加用血栓通注射液,比较两组治疗前后听力阈值及包括血浆黏度、全血黏度、凝血酶时间、凝血酶原时间、活化部分凝血酶原时间、纤维蛋白原、血小板因子在内的血清血液流变学指数。结果 治疗后,两组患者血浆黏度和全血高切黏度、中切黏度、低切黏度、纤维蛋白原、血小板因子水平与治疗前相比均显著降低;凝血酶时间、凝血酶原时间、活化部分凝血酶原时间、血清连接蛋白26和血清连接蛋白30水平均显著升高;两组患者治疗后测得听力阈值较治疗前均显著降低,且观察组听力阈值改善程度显著高于对照组,差异均具有统计学意义(P<0.05)。结论 血栓通注射液联合巴曲酶可有效改善突发性耳聋合并代谢综合征患者血液高凝状态,上调血清连接蛋白26和连接蛋白30水平,有效改善患者内耳微循环,减轻听力损伤。

    Abstract:

    Objective To investigate the effect of Xueshuantong injection in the treatment of sudden deafness complicated with metabolic syndrome and its effect on serum hemorheology.Methods A total of 100 patients with sudden deafness complicated with metabolic syndrome admitted to General Hospital of Huainan Oriental Hospital Group from October 2017 to October 2019 were selected and randomly divided into two groups:the control group (n=50) was given the routine treatment of batroxase,supplementation of vitamins and neuronutrition; the observation group (n=50) was treated with Xueshuantong injection on the basis treatment of the control group. The differences between the two groups before and after treatment were compared, including hearing threshold and serum hemorheology indexes of plasma viscosity, whole blood viscosity, thrombin time, prothrombin time, activated partial prothrombin time, fibrinogen and platelet factor.Results After treatment compared to before treatment, plasma viscosity and whole blood high-cut viscosity, medium-cut viscosity and low-cut viscosity were significantly decreased in two groups, but the levels of thrombin time, prothrombin time, activated partial prothrombin time, Connexin 26 and Connexin 30 were significantly increased; After treatment, the hearing threshold of 2 groups was significantly lower, and the improvement degree of the corresponding indicators in the observation group was significantly higher than that in the control group, which was statistical significance (P<0.05).Conclusion Xueshuantong injection combined with Batroxase can effectively improve the hypercoagulability of blood in patients with sudden deafness complicated with metabolic syndrome, increase the levels of serum connectin 26 and connectin 30, and effectively improve the microcirculation and hearing of patients.

    网友评论
    网友评论
    分享到微博
    发 布
    参考文献
    [1] 王淑芳, 张莉, 张雯雯, 等.鼠神经生长因子在突发性耳聋中的疗效观察[J].中华耳科学杂志, 2016, 14(2):223-228.
    [2] Islamoglu Y, Kesıcı GG, Ercan K, et al. Single sided deafness after sudden hearing loss:late effect on cochlear nerve size[J]. Eur Arch Otorhinolaryngol, 2020; 277(11):3245-3246.
    [3] 李淦峰, 李志海.巴曲酶联合银杏达莫注射液治疗突发性耳聋的临床疗效及安全性评价[J].中国临床药理学杂志, 2016, 32(8):675-677.
    [4] Chen YC, Tsai SJ, Chen JC, et al. Risks of tinnitus, sensorineural hearing impairment, and sudden deafness in patients with non-migraine headache[J]. PLoS One, 2019, 14(9):e0222041.
    [5] 黄智强, 李洁, 喇新军, 等.突发性耳聋患者血液流变学水平及血脂变化的临床意义[J].中国听力语言康复科学杂志, 2017, 15(2):103-106.
    [6] 张潜英, 岳显, 韦军, 等.血栓通联合长春西汀治疗突发性聋的临床观察[J].中国中西医结合耳鼻咽喉科杂志, 2013, 21(6):413-414, 417.
    [7] Si JP, Jiang H, Li YY. Correlation between effectual time and the curative effect in patients with all frequency descending sudden deafness after treatment[J]. Am J Otolaryngol, 2020, 41(5):102621.
    [8] 谢荭, 韩扬, 王敏, 等.微高压氧治疗临床疗效初探[J].中华航海医学与高气压医学杂志, 2020, 27(5):597-600.
    [9] 张炜伟, 冯波, 张彬, 等.地塞米松与甲泼尼龙治疗突发性耳聋的临床疗效对比[J].中国妇幼健康研究, 2017, 28(S1):468.
    [10] 王敏, 雷磊.龙胆泻肝丸联合地塞米松治疗老年突发性耳聋的疗效及对血管内皮功能的影响[J].现代中西医结合杂志, 2020, 29(6):652-655, 666.
    [11] 陈伟, 胡中南, 童钊君, 等.通窍活血汤对青中年突发性耳聋患者的疗效及血液流变学变化分析[J].中医药信息, 2019, 36(1):45-48.
    [12] 王祥升, 姜蕊蕊, 宿江.2型糖尿病并微血管病变突发性聋患者的临床特征及预后分析[J].听力学及言语疾病杂志, 2020, 28(3):282-285.
    [13] 张婷婷, 于晓红, 陈祥雷, 等.代谢综合征与突发性耳聋患病风险相关性分析[J].重庆医学, 2019, 48(24):4187-4189, 4193.
    [14] 王天宇, 刘映岐, 梁才全, 等.巴曲酶联合常规治疗对不同类型突发性聋患者的疗效观察[J].中国耳鼻咽喉颅底外科杂志, 2021, 27(2):196-200.
    [15] 祝召付, 孟中华.血栓通联合低分子右旋糖酐治疗突发性耳聋的疗效观察[J].中华疾病控制杂志, 2012, 16(4):365-366.
    [16] 张先兵, 李勋, 熊平, 等.三七总皂苷对大鼠肝移植排斥反应的影响及相关机制[J].南方医科大学学报, 2019, 39(4):394-400.
    [17] Zhi Y, Wang H, Huang B, et al. Panax Notoginseng Saponins suppresses TRPM7 via the PI3K/AKT pathway to inhibit hypertrophic scar formation in vitro[J]. Burns, 2021, 47(4):894-905.
    [18] 董君君, 胡家才, 杨娜.复方血栓通胶囊治疗下肢动脉硬化闭塞症的临床观察[J].现代中西医结合杂志, 2019, 28(13):1421-1424.
    [19] 刘蕾, 丁世兰, 陈影, 等.注射用血栓通抑制血栓形成及其对血流状态影响的研究[J].中国中药杂志, 2020, 45(10):2446-2453.
    [20] 宋学云, 魏玲玲, 杨杰, 等.注射用血栓通(冻干)联合GM1对糖尿病神经病变患者的临床疗效[J].中成药, 2019, 41(4):794-798.
    [21] Shuja Z, Li L, Gupta S, et al. Connexin26 Mutations Causing Palmoplantar Keratoderma and Deafness Interact with Connexin43, Modifying Gap Junction and Hemichannel Properties[J]. J Invest Dermatol, 2016, 136(1):225-235.
    [22] 解娟, 郑体厚.耳聋左慈丸合复聪通脉开窍针刺法治疗神经性耳聋耳鸣疗效及对血清NO、Connexin 26的影响[J].现代中西医结合杂志, 2017, 26(33):3671-3673.
    [23] García IE, Bosen F, Mujica P, et al. From Hyperactive Connexin26 Hemichannels to Impairments in Epidermal Calcium Gradient and Permeability Barrier in the Keratitis-Ichthyosis-Deafness Syndrome[J]. J Invest Dermatol, 2016, 136(3):574-583.
    [24] 林海龙, 刘学军, 林开春, 等.先天性巨细胞病毒感染新生儿连接蛋白Connexin26基因研究[J].中国耳鼻咽喉头颈外科, 2016, 23(4):221-224.
    引证文献
引用本文

李哲,蔡克万,王政林.血栓通注射液联合巴曲酶治疗突发性耳聋合并代谢综合征的临床观察[J].中国耳鼻咽喉颅底外科杂志,2021,27(5):589-593

复制
分享
文章指标
  • 点击次数:600
  • 下载次数: 274
历史
  • 收稿日期:2021-05-11
  • 在线发布日期: 2021-10-29
温馨提示

本刊唯一投稿网址:www.xyosbs.com
唯一办公邮箱:xyent@126.com
编辑部联系电话:0731-84327210,84327469
本刊从未委托任何单位、个人及其他网站代理征稿及办理其他业务联系,谨防上当受骗!

关闭